EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic Value of Ceramide Dynamics in Patients with Acute Coronary Syndrome

Elena Usova, Alexey Yakovlev, Georgy Kopanitsa, Oleg Metsker, Madina Alieva, Tatiana Makarova, Lev Malishevskii, Ekaterina Murashko, Elizaveta Kessenikh, Sergey Trusov, Asiiat Alieva, Alexandra Konradi

Studies in Health Technology and Informatics · 2024

DOI: 10.3233/shti241087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Studies in Health Technology and Informatics, 2024. Verfasst von Elena Usova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Almazov National Medical Research Centre, Saint-Petersburg, Russia. Hauptthemen laut MEDLINE: Ceramides, Acute Coronary Syndrome, Biomarkers. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A dynamic study of ceramide concentrations and their association with recurrent event risk could enhance our understanding of cardiovascular complications. To assess the prognostic value of ceramide concentrations (Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/24:1), Cer(d18:1/24:0)) and their dynamics in combination with standard clinical and laboratory parameters and therapeutic interventions in ACS patients. Among 110 ACS patients, triple blood sampling was performed for targeted lipidomic analysis using high-performance liquid chromatography-tandem mass spectrometry. All ceramide concentrations peaked at admission and decreased by the 3rd day of hospitalization and at the 3-month follow-up. The difference between Cer(d18:1/18:0) concentration 3 months after hospital discharge and its baseline value on admission was strongly associated with recurrent events, independent of prior statin treatment. The association of the Cer(d18:1/18:0) change from 3rd day of hospitalization and its baseline concentration on admission with prognosis varied depending on the glycemic profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesAcute Coronary SyndromeBiomarkersPrognosisLiquid Chromatography-Mass SpectrometryChromatography, High Pressure LiquidHydroxymethylglutaryl-CoA Reductase InhibitorsLipidomicsHumansMaleFemaleMiddle AgedAged

Stichwörter der Autor:innen

Acute coronary syndromeceramideshigh-performance liquid chromatography-tandem mass spectrometrylipidomic analysismachine learning

Substanzen

CeramidesHydroxymethylglutaryl-CoA Reductase InhibitorsBiomarkers

Autor:innen und Institutionen

  • Almazov National Medical Research Centre, Saint-Petersburg, Russia.

Zitieren

APA

Usova, E., Yakovlev, A., Kopanitsa, G., Metsker, O., Alieva, M., Makarova, T., Malishevskii, L., Murashko, E., Kessenikh, E., Trusov, S., Alieva, A., & Konradi, A. (2024). Prognostic Value of Ceramide Dynamics in Patients with Acute Coronary Syndrome. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti241087

Vancouver

Usova E, Yakovlev A, Kopanitsa G, Metsker O, Alieva M, Makarova T, et al. Prognostic Value of Ceramide Dynamics in Patients with Acute Coronary Syndrome. Studies in Health Technology and Informatics. 2024. doi:10.3233/shti241087

BibTeX
@article{Usova2024,
  author = {Usova, Elena and Yakovlev, Alexey and Kopanitsa, Georgy and Metsker, Oleg and Alieva, Madina and Makarova, Tatiana and Malishevskii, Lev and Murashko, Ekaterina and Kessenikh, Elizaveta and Trusov, Sergey and Alieva, Asiiat and Konradi, Alexandra},
  title = {Prognostic Value of Ceramide Dynamics in Patients with Acute Coronary Syndrome},
  journal = {Studies in Health Technology and Informatics},
  year = {2024},
  doi = {10.3233/shti241087}
}
Kostenlos starten →